Anders Junker

1.6k total citations
28 papers, 547 citations indexed

About

Anders Junker is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Anders Junker has authored 28 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Physiology. Recurrent topics in Anders Junker's work include Liver Disease Diagnosis and Treatment (17 papers), Diet, Metabolism, and Disease (9 papers) and Diet and metabolism studies (5 papers). Anders Junker is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Diet, Metabolism, and Disease (9 papers) and Diet and metabolism studies (5 papers). Anders Junker collaborates with scholars based in Denmark, United States and Norway. Anders Junker's co-authors include Filip K. Knop, Lise Lotte Gluud, Tina Vilsbøll, Jens J. Holst, Nicolai J. Wewer Albrechtsen, Lili Niu, Matthias H. Tschöp, Stephan Sachs, Sophia Doll and Matthias Mann and has published in prestigious journals such as Circulation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anders Junker

25 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anders Junker Denmark	10	253	214	165	127	104	28	547
Hidde H. Huidekoper Netherlands	15	107 0.4×	61 0.3×	208 1.3×	214 1.7×	127 1.2×	44	651
Masashi Miyao Japan	10	198 0.8×	47 0.2×	161 1.0×	87 0.7×	62 0.6×	24	517
Abraham Younoszai United States	5	493 1.9×	216 1.0×	105 0.6×	95 0.7×	89 0.9×	6	585
Anne-Laure Sberna France	7	257 1.0×	192 0.9×	107 0.6×	116 0.9×	74 0.7×	8	484
Kathryn Jean Lucas United States	10	238 0.9×	207 1.0×	113 0.7×	91 0.7×	88 0.8×	22	521
Edip Uçar Türkiye	11	135 0.5×	99 0.5×	58 0.4×	91 0.7×	63 0.6×	21	416
Xiaomin Pan United States	10	265 1.0×	105 0.5×	164 1.0×	88 0.7×	67 0.6×	16	574
Tomoe Kinoshita Japan	12	102 0.4×	301 1.4×	223 1.4×	134 1.1×	58 0.6×	34	592
Robert M. Badeau Finland	13	98 0.4×	91 0.4×	147 0.9×	98 0.8×	77 0.7×	21	587
Klaus-Peter Maier Germany	7	356 1.4×	199 0.9×	134 0.8×	63 0.5×	148 1.4×	8	507

Countries citing papers authored by Anders Junker

Since Specialization

Citations

This map shows the geographic impact of Anders Junker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Junker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Junker more than expected).

Fields of papers citing papers by Anders Junker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Junker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Junker. The network helps show where Anders Junker may publish in the future.

Co-authorship network of co-authors of Anders Junker

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Junker. A scholar is included among the top collaborators of Anders Junker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Junker. Anders Junker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Werge, Mikkel Parsberg, Andreas Möller, Anders Junker, et al.. (2025). The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease. PLoS ONE. 20(6). e0307345–e0307345.

Jensen, Lisette Okkels, Lars Jakobsen, Ashkan Eftekhari, et al.. (2025). Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent. EuroIntervention. 21(11). e617–e628.

Werge, Mikkel Parsberg, Nina Kimer, Anders Junker, et al.. (2024). Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and Research in Hepatology and Gastroenterology. 48(7). 102389–102389. 5 indexed citations

Ytting, Henriette, Mikkel Parsberg Werge, Johan Burisch, et al.. (2024). Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 326(6). G736–G746. 3 indexed citations

MacDonald, Christopher, Sabrina Mai Nielsen, Anders Junker, et al.. (2024). Evolutionary Mismatch and Lifestyle‐Related Diseases: A Study of a 6‐Month Intensive Lifestyle Intervention. Scandinavian Journal of Medicine and Science in Sports. 34(12). e14770–e14770. 1 indexed citations

Beske, Rasmus Paulin, Christian Hassager, Lisette Okkels Jensen, et al.. (2024). Abstract 4137009: Treating Elderly Cardiogenic Shock Patients with a Microaxial Flow Pump; Is It DANGERous?. Circulation. 150(Suppl_1). 1 indexed citations

Kjeldsen, Sasha A. S., Mikkel Parsberg Werge, Marie Winther‐Sørensen, et al.. (2024). Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 327(4). G558–G570. 1 indexed citations

Werge, Mikkel Parsberg, Nina Kimer, Anders Junker, et al.. (2024). Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease. BMC Gastroenterology. 24(1). 22 indexed citations

Werge, Mikkel Parsberg, Andreas Möller, Anders Junker, et al.. (2023). Postprandial dysfunction in fatty liver disease. Physiological Reports. 11(8). e15653–e15653. 8 indexed citations

10.

Werge, Mikkel Parsberg, et al.. (2021). Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine. 10(3). 404–404. 1 indexed citations

11.

Junker, Anders, Karen Vagner Danielsen, E. Dahl, et al.. (2020). Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. World Journal of Clinical Cases. 8(9). 1642–1650. 7 indexed citations

12.

Bagger, Jonatan I., Katrine Bagge Hansen, Anders Junker, et al.. (2020). No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect. Endocrine Connections. 9(12). 1221–1232. 4 indexed citations

13.

Kimer, Nina, et al.. (2020). Experience from a COVID-19 first-line referral clinic in Greater Copenhagen.. PubMed. 67(9). 4 indexed citations

14.

Milman, Nils, et al.. (2019). Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect. Gastroenterology Research. 12(5). 221–232. 27 indexed citations

15.

Albrechtsen, Nicolai J. Wewer, Anders Junker, Mette Christensen, et al.. (2017). Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 314(1). G91–G96. 76 indexed citations

16.

Junker, Anders, Lise Lotte Gluud, Jens J. Holst, Filip K. Knop, & Tina Vilsbøll. (2016). Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia. Journal of Internal Medicine. 279(5). 485–493. 66 indexed citations

17.

Junker, Anders, Lise Lotte Gluud, Gerrit van Hall, et al.. (2015). Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 64(4). 908–915. 24 indexed citations

18.

Junker, Anders, Lise Lotte Gluud, Jens J. Holst, Filip K. Knop, & Tina Vilsbøll. (2015). Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis. Journal of Gastroenterology and Hepatology. 30(10). 1522–1528. 18 indexed citations

19.

Junker, Anders, Lise Lotte Gluud, Jens Pedersen, et al.. (2014). A 25-Year-Old Woman with Type 2 Diabetes and Liver Disease. Case Reports in Gastroenterology. 8(3). 398–403. 3 indexed citations

20.

Junker, Anders, Bodil Als‐Nielsen, Christian Gluud, & Lise Lotte Gluud. (2014). Dopamine agents for hepatic encephalopathy. Cochrane Database of Systematic Reviews. 2014(2). CD003047–CD003047. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact